Ultrasound-guided Interscalene Block Versus Infraspinatus-Teres Minor Plane Block in Shoulder Arthroscopy
Launched by MISR UNIVERSITY FOR SCIENCE AND TECHNOLOGY · Jun 3, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of pain relief for patients undergoing shoulder arthroscopy, which is a type of surgery on the shoulder. The researchers want to find out which method works better and is safer: the Interscalene block (ISB) or the Infraspinatus-Teres minor (ITM) block. Both techniques involve using ultrasound to guide the injection of anesthetic medication to help manage pain after the surgery.
The trial will include 46 patients aged between 20 and 70 who are generally healthy and scheduled for this type of surgery. Participants will be randomly assigned to one of the two groups before they receive general anesthesia. They will be monitored for pain relief, how long the pain relief lasts, any side effects, and their overall satisfaction after the surgery. This information will help doctors understand which pain management technique might be better for patients in the future. If you or a family member are interested in participating, you would need to meet specific health criteria and give your consent to join the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 20 to 60,
- • ASA classification I or II,
- • scheduled for arthroscopic shoulder surgery,
- • will be randomized 1:1 into two groups before the induction of general anesthesia (GA)
- Exclusion Criteria:
- • Patients who refuse participation.
- • Have allergies to local anesthetics.
- • Phrenic nerve dysfunction.
- • Chronic opioid use.
- • ASA III or higher classification.
- • Coagulopathy.
- • Severe chronic obstructive pulmonary disease.
- • Local infection at the injection site
About Misr University For Science And Technology
MISR University for Science and Technology is a leading institution dedicated to advancing healthcare and scientific research through innovative clinical trials. With a strong focus on interdisciplinary collaboration, the university leverages its diverse expertise to address pressing medical challenges and enhance patient outcomes. Committed to ethical research practices and regulatory compliance, MISR University fosters a robust environment for clinical investigation, aiming to contribute valuable insights to the global medical community. Through its rigorous methodologies and emphasis on scientific excellence, the university strives to translate research findings into tangible health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, , Egypt
Patients applied
Trial Officials
Mohammed Hany Kamal, Prof. of anesthesia and pain
Study Chair
Misr University for Science and Technolog
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported